Managing Metastatic Prostate Cancer In Your Urological Oncology Practice

1. Introduction
K. C. Balaji

2. Pathophysiology of Castration-Resistant Prostate Cancer
Justin C. Penticuff, Natasha Kyprianou

3. Androgen Receptor Signaling in Castration Resistant Prostate Cancer
Yu Zhao, Donald J. Tindall, Haojie Huang

4. Non-androgen Signaling Pathways in Castration-Resistant Prostate Cancer
Sivanandane Sittadjody, Thilakavathy Thangasamy, Bita NickKolgh, K. C. Balaji

5. Predictive Models in Castration Resistant Prostate Cancer
Tao Cui, Michael W. Kattan

6. Docetaxel in Advanced and Castration Resistant Prostate Cancer
Daniel P. Petrylak, Navid Hafez

7. Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate
Ben Fulton, Robert J. Jones

8. Cancer Vaccines in Castration Resistant Prostate Cancer—An Evolution in Design
Susan F. Slovin

9. Abiraterone for the Treatment of mCRPC
Zafeiris Zafeiriou, Niven Mehra, Johann S. Bono

10. Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Jeffrey Shevach, Bridget K. Marcellino, William K. Oh, Che-Kai Tsao

11. Radium-223 in Metastatic Castrate Resistant Prostate Cancer
Tu Dan, Noelle Williams, Robert B. Den

12. Cabazitaxel for the Treatment of Prostate Cancer
Michael Kolinsky, Niven Mehra, Johann S. de Bono

13. Sequencing Therapies in Metastatic Castration—Resistant Prostate Cancer
Michael T. Schweizer, Bruce Montgomery

14. Bone Preservation Strategies for Men on Androgen Deprivation Therapy
Charles C. Peyton, K. C. Balaji

15. Novel Therapies in Castration-Resistant Prostate Cancer
Tyler Lash, Rhonda L. Bitting

Avainsanat: Medicine & Public Health, Urology, Oncology